5167 POSTER A Multicenter Randomized Phase II Study of KRN125 (Pegfilgrastim) to Determine the Optimal Dosage in Japanese Breast Cancer Patients Receiving TAC Treatment

Authors:
  • NMN. Masuda
    N. Masuda
  • SNS. Nakamura
    S. Nakamura
  • YIY. Ito
    Y. Ito
  • YTY. Tokuda
    Y. Tokuda
  • KTK. Tamura
    K. Tamura

Abstract
No abstract available